Microsaic Systems plc Directorate Change (0063L)
28 September 2016 - 4:01PM
UK Regulatory
TIDMMSYS
RNS Number : 0063L
Microsaic Systems plc
28 September 2016
28 September 2016
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Retirement of Chairman
Microsaic Systems plc (AIM: MSYS), the developer of chip-based
mass spectrometry instruments, has been informed by the Company's
Chairman, Colin Nicholl, that he shall retire from the Board on the
31 January 2017. The Board, in consultation with its nominated
adviser N+1 Singer, has initiated a process to identify and elect a
new Chairperson.
Senior Non-Executive Director Eric Yeatman commented: "Colin has
been a strong guiding influence to Microsaic, particularly as
Chairman since July 2013. During this period, the Company has
undertaken important changes, including the introduction of a new
management team and corporate strategy, and most recently a
successful corporate financing to ensure the ongoing financial
stability for the business. On behalf of the Board, I would like to
express our great appreciation for his contribution to the
leadership of the Company, and his continuing commitment to the
successful implementation of its strategy."
Colin Nicholl added: "Microsaic has unique technologies that
have the potential to make a positive impact in a wide range of
application areas. With a new executive team in place and with its
financial stability ensured for the next few years, it is the right
time to step down and enable the company to seek a new Chairperson
who will lead the board during the next exciting phase of
Microsaic's development."
Enquiries:
Microsaic Systems plc
Jim Ramage, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser
& Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
Citigate Dewe Rogerson
(Financial PR)
Mark Swallow, Marine Perrier +44 (0)20 7282 2948/1068
About Microsaic Systems
Microsaic Systems plc is a high technology company developing
chip-based, bench-top mass spectrometry ("MS") instruments that are
designed to improve the efficiency of Pharma R&D. MS is an
analytical technique of choice for biochemists across many industry
sectors.
Microsaic aims to bring routine MS analysis to the
pharmaceutical scientist, providing powerful methods of analysis to
enable earlier decision making relating to product identification,
purity and bioactivity.
The Company is working with established global companies in
preparative and purification science with expertise in Pharma and
life sciences to co-develop new, integrated and optimised,
application-specific, solutions to improve productivity in the
development of small molecule and novel biologic (peptides,
antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's
smallest MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. The Company is
also developing new MS systems, based on its patented chip
technologies, to address further areas of emerging need in Pharma
R&D.
Microsaic Systems was established in 2001 by a team including
founders from Imperial College London, and was admitted to AIM in
2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOADDLFLQKFLBBV
(END) Dow Jones Newswires
September 28, 2016 02:01 ET (06:01 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2024 to Jun 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Jun 2023 to Jun 2024